[1]
W. R. Devi, M. D. Prenggono, P. AP, and I. B, “Differences of Bone Marrow Features and BCR-ABL Variants in Chronic Granulocytic Leukemia Post Tyrosine Kinase Inhibitor Therapy”, Indonesian J. Clin. Pathol. Med. Lab., vol. 26, no. 2, pp. 217–222, Mar. 2020.